Core Viewpoint - BGM Group is set to release its unaudited financial results for the first half of 2025 on July 24, 2025, before U.S. financial markets open [1] Company Overview - BGM Group Ltd. focuses on technology sectors including AI applications, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [2] AI Application Implementation - The company utilizes advanced analytics and AI Agent technology through its platforms Du Xiao Bao and Bao Wang to deliver AI solutions and intelligent robot services to insurance companies, brokers, and consumers [3] - Services encompass sales and marketing, underwriting assessment, claims processing, and customer service, with capabilities in consumer data analysis and customized service provision [3] Biopharmaceuticals Division - BGM's biopharmaceutical division produces oxytetracycline API, crude heparin sodium, and licorice preparations, serving global markets in animal husbandry, pharmaceuticals, and drug retail [4] - The integration of AI-assisted decision-making enhances production efficiency, supply chain optimization, and market trend prediction, providing a scientific basis for management decisions and high-quality products for consumers [4]
BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025